View Profile
Base
| Bio | 2017-Stage 2A nasal tip; wide excision and graft to nose; SLNB negative. 2020- Stage 4 w/bone mets. Pembrolizumab started 8/25/20. Braf neg. 2021- Complete metabolic response 6/17/21 (10 months)! 2022- End Pembro 1/18/22 after 18 months; staying on Xgeva for hx bone mets and osteoporosis. Surveillance CT scans every 3 months. |
| Display Name | ThinkingPositive |
| I am | the patient |
| Initial Diagnosis Month | |
| Initial Diagnosis Year | |
| Stage at Diagnosis | |
| Current Stage |